[Cellular adhesion molecule (CD44) in ovarian tumors]

Area of Science:

• Oncology
• Immunology
• Biomarker Discovery

Background:

• Ovarian tumors present a diagnostic challenge, necessitating reliable methods for differentiation.
• Adhesion molecules, such as CD44, play roles in tumor progression and metastasis.

Purpose of the Study:

• To evaluate the diagnostic utility of CD44 adhesion molecule detection in ovarian tumors.
• To assess the clinical significance of CD44 levels in peripheral blood lymphocytes (PBL) and neoplastic tissues.

Main Methods:

• Quantitative analysis of CD44 content in PBL and tumor tissues from 106 ovarian tumor patients (50 benign, 56 malignant).
• Utilized a flow cytometric-immunological method for precise measurement.

Main Results:

• Significantly higher CD44 levels were observed in PBL of malignant ovarian tumor patients compared to benign cases and controls.
• CD44 content was higher in neoplastic tissues than in PBL within the malignant tumor group.
• CD44 levels in PBL showed a gradual decrease following surgical intervention.

Conclusions:

• Flow cytometry analysis of CD44 in PBL and tumor tissues serves as a valuable parameter for distinguishing benign from malignant ovarian tumors.
• This method aids in the early detection of recurrence or metastasis in malignant ovarian cancer.